Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FIND Genomics is a private bioinformatics and research software company developing tools to improve reproducibility in cell-based biomedical research. Its main product, FIND Cell, is a cloud-based cell culture management and cell line tracking platform that helps laboratories document passaging, freezer inventory, genetic validation, contamination checks, and lineage history. The company also offers a specialized sequencing-enabled workflow for cell line authentication and genetic stability assessment, including support for low-coverage whole-genome sequencing analysis. FIND Genomics appears to serve academic laboratories, biotechnology companies, pharmaceutical organizations, and regenerative medicine researchers rather than developing therapeutics of its own. The business is best characterized as a health-related software/platform company focused on preclinical research operations and quality control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FIND Genomics.